Transvaginal Mesh Study Suggests FDA Took Too Long to Act
Posted on March 6th, 2020
Women treated with transvaginal mesh are 40% more likely to need surgery later. Friday, March 6, 2020 – A study of over 54,000 women who were treated with transvaginal mesh for pelvic organ prolapse (POP) revealed that nearly 1 in 5 endure complications that will likely affect them for the rest of their lives. Just as… Read More
Boston Scientific, Coloplast Ordered to Stop Selling Surgical Mesh
Posted on December 6th, 2019
FDA Pulls Transvaginal Mesh Due to Safety Concerns Friday, December 6, 2019 – Two of the most prominent companies in the transvaginal mesh industry, Boston Scientific and Coloplast, have been ordered by the US Food and Drug Administration to stop selling surgical mesh used to treat pelvic organ prolapse (POP), including posterior and anterior compartment prolapse. The… Read More
Why is Transvaginal Mesh a Problem?
Posted on May 23rd, 2019
Onder Law Firm is dedicated to helping women who have experienced pain, suffering, and medical bills related to use of transvaginal mesh, and to making sure that dangerous products like it are pulled from profit-driven use, regardless of the harm they may cause. Thursday, May 23, 2019 – For years, transvaginal mesh was used despite warnings… Read More